Ophthotech Corp Now Covered by Analysts at Leerink Swann (OPHT)
Investment analysts at Leerink Swann initiated coverage on shares of Ophthotech Corp (NASDAQ:OPHT) in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $37.00 price target on the stock. Leerink Swann’s target price would indicate a potential upside of 8.82% from the company’s current price.
Ophthotech Corp (NASDAQ:OPHT) traded down 2.66% during mid-day trading on Monday, hitting $34.00. The stock had a trading volume of 288,118 shares. The stock has a 50-day moving average of $0. and a 200-day moving average of $0.. The company’s market cap is $1.024 billion.
Ophthotech Corporation is a biopharmaceutical company specializing in the development of therapeutics to treat diseases of the eye.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.